Pharmaxis Builds Senior Management Team
Release Date: 17/02/2009 12:00am
Pharmaceutical company Pharmaxis (ASX:PXS, Nasdaq:PXSL) today announced that it had appointed Dr Howard Fox to its senior management team in the position of Chief Medical Officer. Dr Fox will assume responsibility for regulatory affairs, pharmacovigilance and medical affairs. Clinical Operations will continue to report to the Medical Director, Dr Brett Charlton.